Pertussis outbreak in recently vaccinated children in a kindergarten
in Ljubljana during a resurgence in pertussis incidence
Pertussis (whooping cough) is a mandatorily notifiable disease in Slovenia
and since 1959, there has been an active national immunisation programmme.
Since the start of this programme, the annual number of notified cases has
fallen sharply [1]. Children are vaccinated (DTP (acellular)-Hib) with three
doses at one to three month intervals, starting at the age of three months,
with a booster one year after the third dose. Slovenia started to import acellular
pertussis vaccine in 1997, and acellular vaccine has been used exclusively
since 1999.
Table 1. Notified cases of whooping cough* from 1998 to
2002 in Slovenia
| Year |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
| Number of notifications of pertussis in
Slovenia |
25 |
23 |
34 |
77 |
30 |
182 |
113 |
| Morbidity / 100 000 inhabitants |
1.2 |
1.1 |
1.7 |
3.8 |
1.5 |
30.2 |
18.7 |
Table 2. Notified cases of whooping cough* in the Ljubljana
health region in years 1998 to 2004
| Year |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
| Number of notifications of pertussis in
the Ljubljana health region |
6 |
0 |
10 |
23 |
3 |
44 |
46 |
| Morbidity / 100 000 inhabitants |
1.0 |
0 |
1.7 |
3.8 |
0.5 |
7.3 |
7.6 |
The Ljubljana health region has about 600 000 inhabitants (about one third
of the entire Slovene population).
Outbreak of pertussis in a Ljubljana kindergarten, August 2004
The Institute of Public Health of Ljubljana was notified of a case of pertussis
in a 16 month old boy, on 31 August 2004. The boy had received three doses
of pertussis vaccination in the 12 months before becoming ill. The diagnosis
was laboratory confirmed (RT-PCR and culture isolation).
A diagnosis of pertussis in the mother of the infant was also laboratory
confirmed (IgM > 40,2 IE/ml, IgG > 500 IE/ml, Ig A 22.6 IE/ml). She
had been fully immunised against pertussis in childhood. She worked in a
prison where she had many contacts. There was no information about a possible
source of infection.
The boy (index case), attended a kindergarten in Ljubljana. Four days after
his onset of illness, another case of pertussis was confirmed (RT-PCR and
isolation in culture) in the same group of children. The second case, also
a boy, had been in close contact with the index case.
Epidemiological and clinical investigations revealed that at least three
of the 12 children in the same kindergarten group as the index case had
pertussis symptoms. Another six children in the same group had acute respiratory
infection symptoms. All nine suspected cases were also laboratory tested
(RT-PCR), but the results were negative. The children in the kindergarten
group were between one and two years old. All the children had been immunised
with three doses of DTP(acellular)-HiB. Less than a year had passed since
the last immunisation. Children in other groups in the kindergarten were
healthy, as were the teachers and parents of the ill children.
Control measures
All children in the same kindergarten group as the index case were given
antibiotics (azithromycin), as were the children who were family contacts
of the children with symptoms characteristic of pertussis. The kindergarten
was thoroughly cleaned and disinfected.
Discussion
Whooping cough is highly infectious, and before vaccination was introduced,
almost all children became infected [2]. However, vaccination does not prevent
the infection or asymptomatic carriage, and immunity wanes after vaccination.
In recent years in the United States and Europe (for example, the Netherlands)
pertussis in adolescents and young adults has been diagnosed more frequently
[3].
The reason for a small outbreak of pertussis remains unclear. The cases
were in young children who had been vaccinated according to the national
vaccination programme. The occurrence of smaller outbreaks of whooping cough
is not unexpected; what is unexpected is an outbreak in children who had
all been vaccinated against the disease with acelullar vaccine less than
one year previously.
Some hypotheses for this apparent vaccine failure are:
- antigenic shift so that the circulating strains and vaccination
strains of Bordetella pertussis diverge and vaccine efficacy
is reduced
|
- other factors, alone or in combination
|
To investigate the first hypothesis, B. pertussis strains that
have been collected in Slovenia in recent years, should be characterised
by sequencing surface protein genes. Changes in circulating B. pertussis
have been reported in the Netherlands [2] and Australia [4]. The extent
to which bacterial polymorphisms affect vaccine efficacy probably depends
on the vaccine used [2], on the proportion of polymorphic bacteria in the
human population, and other factors. Further studies are required to assess
the effect of the antigen changes on the efficacy of pertussis vaccines.
Paediatricians and general practitioners should be aware of the possibility
of pertussis occurrence in both children and adults. Continued surveillance
of Bordetella strains/genome is very important..
Footnote: *Case definition used for pertussis
notification in Slovenia:
A case is defined as a person with:
• either cough continuing for at least two weeks or cough
in paroxysms;
• or paroxysms of coughing without intervening inhalation that are followed
by a characteristic crowing or high pitched inspiratory whoop;
• or paroxysms of coughing followed by vomiting;
• or a cough with no other reason [1].
The laboratory criteria are:
• demonstration of a specific pertussis antibody response in absence of
recent vaccination;
• detection of nucleic acid;
• isolation of Bordetella pertussis from a clinical
specimen.
A possible case is one that meets the clinical case definition;
A probable case is one that meets the clinical case definition and has epidemiological
link;
A confirmed case is one that is laboratory confirmed.